A novel automated microchip flow‐chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2011-10-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1111/j.1538-7836.2011.04464.xPMID 21827607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet polyphosphate: an endogenous activator of coagulation factor XII

  2010cited by this paper
• Tissue factor activity under flow.

  2010cited by this paper
• Bedside Evaluation of Thienopyridine Antiplatelet Therapy

  2009cited by this paper
• Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.

  2008cited by this paper
• Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study

  2008cited by this paper
• Coagulation Monitoring: Current Techniques and Clinical Use of Viscoelastic Point-of-Care Coagulation Devices

  2008cited by this paper
• Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

  2008cited by this paper
• Intrinsic Pathway of Coagulation and Arterial Thrombosis

  2007cited by this paper
• In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban

  2007cited by this paper
• Point-of-Care Platelet Function Testing

  2007cited by this paper
• Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

  2006cited by this paper
• Coagulation under Flow: The Influence of Flow-Mediated Transport on the Initiation and Inhibition of Coagulation

  2006cited by this paper
• Spatial and temporal dynamics of the endothelium

  2005cited by this paper
• Spatial and temporal dynamics of the endothelium

  2005cited by this paper
• Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation.

  2004cited by this paper
• Electron Microscopic Evaluations of Clot Morphology During Thrombelastography®

  2004cited by this paper
• Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r‐hirudin in a human ex vivo model of arterial thrombosis

  2003cited by this paper
• Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban

  2003cited by this paper
• Anticoagulants (Thrombin Inhibitors) and Aspirin Synergize With P2Y12 Receptor Antagonism in Thrombosis

  2003cited by this paper
• Thrombi in acute coronary syndromes : revisited and revised.

  2000cited by this paper
• Thrombi in Acute Coronary Syndromes Revisited and Revised

  2000cited by this paper
• Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.

  1999cited by this paper
• Blood flow and antithrombotic drug effects.

  1998cited by this paper
• BCH-2763, a Novel Potent Parenteral Thrombin Inhibitor, Is an Effective Antithrombotic Agent in Rodent Models of Arterial and Venous Thrombosis – Comparisons with Heparin, r-Hirudin, Hirulog, Inogatran and Argatroban

  1998cited by this paper
• Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions.

  1998cited by this paper
• Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

  1997cited by this paper
• Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

  1997cited by this paper
• Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

  1996cited by this paper
• Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.

  1996cited by this paper
• The Effect of Fibrin Clots and Clot-Bound Thrombin on the Development of Platelet Procoagulant Activity

  1995cited by this paper
• Description of an In Vitro Platelet Function Analyzer-PFA-100™

  1995cited by this paper
• The Effects of Flow on Blood Coagulation and Thrombosis

  1993cited by this paper
• Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin.

  1990cited by this paper
• The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendothelium

  1986cited by this paper
• Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.

  1986cited by this paper
• Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.

  1986cited by this paper
• Isolation and characterization of trypsin inhibitor from opaque-2 corn seeds.

  1977cited by this paper

• Methodological and Pathophysiological Considerations in Obesity-Associated Thrombosis.

  2026cites this paper
• Megakaryocytes transfer mitochondria to bone marrow mesenchymal stromal cells to lower platelet activation

  2025cites this paper
• The EPA oxylipin, 12-HEPE, directly regulates human platelet activity

  2025cites this paper
• Total thrombus formation analysis in patients with myeloid neoplasia and thrombocytopenia

  2025cites this paper
• Fractions from Sea Buckthorn Seeds and Their Bioactive Ingredients as Modulators of Human Blood Platelet Response In Vitro: The Role of Thermal Processing

  2025cites this paper
• Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters

  2025cites this paper
• Phytochemical Analysis of the Extract from Berries of Schisandra chinensis Turcz. (Baill.) and Its Anti-Platelet Potential In Vitro

  2025cites this paper
• Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma

  2024cites this paper
• Subclinical leaflet thrombus in patients with severe aortic stenosis and atrial fibrillation -ENRICH-AF TAVI study

  2024cites this paper
• New Findings Regarding the Effects of Selected Blue Food Colorants (Genipin, Patent Blue V, and Brilliant Blue FCF) on the Hemostatic Properties of Blood Components In Vitro

  2024cites this paper
• Optical coherence tomography imaging of coronary thrombosis developed after rotational atherectomy despite appropriate antithrombotic therapy

  2024cites this paper
• Elevated Leukocyte Count and Platelet-Derived Thrombogenicity Measured Using the Total Thrombus-Formation Analysis System in Patients with ST-Segment Elevation Myocardial Infarction

  2024cites this paper
• Evaluating thrombosis risk and patient-specific treatment strategy using an atherothrombosis-on-chip model.

  2024cites this paper
• A novel haemodilution chip mounted on the total thrombus‐formation analysis system, a flow chamber system, enables stable analysis of platelet products under low platelet concentration/high shear conditions

  2024cites this paper
• Advancing microfluidic point-of-care platelet function tests: opportunities and challenges from bench to market

  2024cites this paper
• The Utility of Total Thrombus‐Formation Analysis System (T‐TAS) in the Thrombosis and Hemostasis Field: A Scoping Review

  2024cites this paper
• Total Thrombus-Formation System in Patients with Peripheral Artery Disease

  2024cites this paper
• Synthesis, Biological Evaluation and Reversal of Sulfonated Di‐ and Triblock Copolymers as Novel Parenteral Anticoagulants

  2024cites this paper
• Anti-Platelet Activity of Sea Buckthorn Seeds and Its Relationship with Thermal Processing

  2024cites this paper
• Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects

  2023cites this paper
• Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

  2023influential citation
• BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention

  2023cites this paper
• Use of heated tobacco products (IQOS) causes an acute increase in arterial stiffness and platelet thrombus formation.

  2023cites this paper
• Pediatric Mesangial Proliferative Glomerulonephritis Has Increased the Platelet Thrombus Formation Potentials under High-Shear Flow Condition

  2023cites this paper
• The oxylipin analogue CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor.

  2023cites this paper
• Electronic Cigarette Vaping with Nicotine Causes Increased Thrombogenicity and Impaired Microvascular Function in Healthy Volunteers: A Randomised Clinical Trial

  2023cites this paper
• Response of human blood platelets to preparations from leaves of Paulownia Clon in Vitro 112.

  2023cites this paper
• Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial

  2023cites this paper
• Evaluation of fibrinolysis by real time-imaging analysis

  2023cites this paper
• The changes of blood platelet reactivity in the presence of Elaeagnus rhamnoides (L.) A. Nelson leaves and twig extract in whole blood.

  2023cites this paper
• Hemostatic disorders in patients with infective endocarditis undergoing urgent surgical valve replacement - Rethinking current beliefs.

  2023cites this paper
• Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models.

  2023cites this paper
• Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention

  2023cites this paper
• A novel quantitative method to evaluate the contribution of platelet products to white thrombus formation in reconstituted blood under flow conditions

  2023cites this paper
• Extract from Sea Buckthorn Seeds—A Phytochemical, Antioxidant, and Hemostasis Study; Effect of Thermal Processing on Its Chemical Content and Biological Activity In Vitro

  2023cites this paper
• Blood Cell Separation Using Polypropylene-Based Microfluidic Devices Based on Deterministic Lateral Displacement

  2023cites this paper
• Von Willebrand factor in diagnostics and treatment of cardiovascular disease: Recent advances and prospects

  2022cites this paper
• Antiplatelet and Anticoagulant Activity of Isorhamnetin and Its Derivatives Isolated from Sea Buckthorn Berries, Measured in Whole Blood

  2022cites this paper
• Atherothrombosis‐on‐Chip: A Site‐Specific Microfluidic Model for Thrombus Formation and Drug Discovery

  2022cites this paper
• The in vitro anti-platelet activities of plant extracts from the Asteraceae family.

  2022cites this paper
• Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial

  2022cites this paper
• Qualitative and Quantitative Analysis of Secondary Metabolites in Morphological Parts of Paulownia Clon In Vitro 112® and Their Anticoagulant Properties in Whole Human Blood

  2022cites this paper
• Malnutrition-associated high bleeding risk with low thrombogenicity in patients undergoing percutaneous coronary intervention.

  2022cites this paper
• Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry

  2022cites this paper
• Utility of the Total Thrombus-Formation Analysis System as a Tool for Evaluating Thrombogenicity and Monitoring Antithrombotic Therapy in Pediatric Fontan Patients

  2022cites this paper
• The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk—A Systematic Review

  2021cites this paper
• Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia

  2021cites this paper
• Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study

  2021cites this paper
• Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro

  2021cites this paper
• Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison

  2021cites this paper
• Anti-Platelet Properties of Phenolic and Nonpolar Fractions Isolated from Various Organs of Elaeagnus rhamnoides (L.) A. Nelson in Whole Blood

  2021cites this paper
• Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson.

  2021cites this paper
• The Assessment of the Platelet Function During the Acute Phase of ST-segment Elevation Myocardial Infarction in Essential Thrombocythemia

  2021cites this paper
• Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis

  2021cites this paper
• Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.

  2021cites this paper
• Analysis of blood clotting with the total thrombus analysis system in healthy dogs

  2021cites this paper
• The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions

  2021cites this paper
• The Changes of Blood Platelet Reactivity in the Presence of Crude Extracts Isolated from Leaves and Twigs of Elaeagnus Rhamnoides (L.) A. Nelson Measuring in Whole Blood

  2021cites this paper
• The Anti-platelet and Anticoagulant Potential of Isorhamnetin and Its New Derivatives Isolated From Sea Buckthorn Fruits in Whole Blood

  2021cites this paper
• Temporary Rise in Blood Thrombogenicity in Patients with Acute Myocardial Infarction

  2021influential citation
• Preparations from selected cucurbit vegetables as antiplatelet agents

  2021cites this paper
• The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner

  2021cites this paper
• Modelling Human Physiology on-Chip: Historical Perspectives and Future Directions

  2021cites this paper
• Endometriosis is associated with an increased whole-blood thrombogenicity detected by a novel automated microchip flow-chamber system (T-TAS®).

  2021cites this paper
• Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition

  2021cites this paper
• A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis

  2020cites this paper
• Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease

  2020cites this paper
• Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

  2020cites this paper
• E8002 Inhibits Peripheral Nerve Adhesion by Enhancing Fibrinolysis of l-Ascorbic Acid in a Rat Sciatic Nerve Model

  2020cites this paper
• Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease.

  2020cites this paper
• Evaluation of the potential utility of the total thrombus‐formation analysis system in comparison to the platelet function analyser in subjects with primary haemostatic defects

  2020cites this paper
• New methodological approaches for assessing thrombus formation in cardiovascular disease.

  2020cites this paper
• A microchip flow‐chamber assay screens congenital primary hemostasis disorders

  2020cites this paper
• Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus

  2020cites this paper
• Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.

  2020cites this paper
• A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia

  2020cites this paper
• Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.

  2020cites this paper
• Platelet production using adipose‐derived mesenchymal stem cells: Mechanistic studies and clinical application

  2020cites this paper
• Flavonoid Preparations from Taraxacum officinale L. Fruits—A Phytochemical, Antioxidant and Hemostasis Studies

  2020cites this paper
• Haernatologica HAEMATOL / 2019 / 235549 Version 3 Novel aptamer to von Willebrand factor A 1 domain ( T AGX-0004 ) shows total inhibition of thrombus formation superior to ARC 1779 and comparable to caplacizumab

  2020cites this paper
• Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

  2019cites this paper
• Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab.

  2019cites this paper
• Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system

  2019cites this paper
• Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study

  2019cites this paper
• Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease

  2019cites this paper
• The Impact of Erythrocytes Injury on Blood Flow in Bionic Arteriole with Stenosis Segment

  2019cites this paper
• Microfluidic and computational study of structural properties and resistance to flow of blood clots under arterial shear

  2019cites this paper
• Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis

  2019cites this paper
• Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

  2019cites this paper
• Clinical Tests of Platelet Function

  2019cites this paper
• Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab.

  2019cites this paper
• Platelet Function Testing in Clinical Research Trials

  2019cites this paper
• Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation — The ATTRACTIVE-TTAS study

  2019cites this paper
• Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents.

  2019cites this paper
• Comparison between blood coagulability in the intra-atrial and peripheral regions during theacute phase after rapid atrial pacing

  2018influential citation
• Laboratory investigation of platelet function in patients with mild bleeding disorders

  2018cites this paper
• Inhibition by Ethanol of Shear Stress-Induced Formation of Platelet Thrombi in Whole Blood

  2018cites this paper
• Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis

  2018cites this paper
• Uric acid enhances alteplase-mediated thrombolysis as an antioxidant

  2018cites this paper
• Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.

  2018cites this paper